Finance

Lists
300436:SHE
Fujian Cosunter Pharmaceutical Co Ltd
CN¥81,68
-0,16%
(-0,13) 1D
15 Okt., 15:04:01 GMT+8  ·   CNY
All symbols
SymbolPriceChange% Change
Generating top insights for 300436...
Open
CN¥79,99
High
CN¥86,88
Low
CN¥79,99
Mkt. cap
12,90 mjd
Avg. vol.
2,81 m
Volume
5,46 m
52-wk high
CN¥149,00
52-wk low
CN¥73,60
EPS
-CN¥1,38
Shares outstanding
168,03 m
No. of employees
715
Open
CN¥79,99
High
CN¥86,88
Low
CN¥79,99
Mkt. cap
12,90 mjd
Avg. vol.
2,81 m
Volume
5,46 m
52-wk high
CN¥149,00
52-wk low
CN¥73,60
EPS
-CN¥1,38
Shares outstanding
168,03 m
No. of employees
715
News stories
From web sources and news partners
About Fujian Cosunter Pharmaceutical Co Ltd
CEO-
Employees715
Founded1999
Headquarters-
SectorPharmaceutical industry
Websitecosunter.com
Previous reportsAll values in CNY
Loading Previous Earnings...
Revenue
Net income
All values in CNY
Sep. 2025
Des. 2025
Mrt. 2026
Jun. 2026
Revenue
106,98 m
100,54 m
98,44 m
121,71 m
Cost of goods sold
32,68 m
71,64 m
32,53 m
74,28 m
Cost of revenue
32,68 m
71,64 m
32,53 m
74,28 m
Research and development expenses
12,80 m
4,28 m
13,49 m
9,40 m
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
85,44 m
78,09 m
69,44 m
72,06 m
Operating expense
100,11 m
85,32 m
83,15 m
85,73 m
Total operating expenses
132,79 m
156,96 m
115,68 m
160,01 m
Operating income
-25,81 m
-56,43 m
-17,24 m
-38,29 m
Other non operating income
-987,89 k
768,31 k
-72,70 k
-220,40 k
EBT including unusual items
-44,63 m
-122,10 m
-27,04 m
-41,74 m
EBT excluding unusual items
-37,13 m
-64,23 m
-25,93 m
-47,53 m
Income tax expense
3,86 m
835,64 k
3,08 m
4,16 m
Effective tax rate
-8,64%
-0,68%
-11,38%
-9,97%
Other operating expenses
1,75 m
2,27 m
-90,80 k
4,35 m
Net income
-44,90 m
-106,26 m
-25,92 m
-42,21 m
Net profit margin
-41,97%
-105,70%
-26,34%
-34,68%
Earnings per share
-
-
-
-
Interest and investment income
13,03 k
30,43 k
134,30 k
-
Interest expense
-8,30 m
-7,88 m
-8,75 m
-9,10 m
Net interest expenses
-8,29 m
-7,85 m
-8,62 m
-9,10 m
Depreciation and amortization charges
-
-
-
-
EBITDA
-2,17 m
-33,43 m
5,76 m
-19,57 m
Gain or loss from assets sale
-
-9,89 k
-
201,00
AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer
Google-programme